about
A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccineUsing HSV-1 genome phylogenetics to track past human migrationsAgents and strategies in development for improved management of herpes simplex virus infection and disease.Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1Multiplex sequencing of seven ocular herpes simplex virus type-1 genomes: phylogeny, sequence variability, and SNP distributionIn vivo ablation of CD11c-positive dendritic cells increases susceptibility to herpes simplex virus type 1 infection and diminishes NK and T-cell responses.Sequence variation in the herpes simplex virus U(S)1 ocular virulence determinant.Recombination Analysis of Herpes Simplex Virus 1 Reveals a Bias toward GC Content and the Inverted Repeat Regions.Quantitative Trait Locus Based Virulence Determinant Mapping of the HSV-1 Genome in Murine Ocular Infection: Genes Involved in Viral Regulatory and Innate Immune Networks Contribute to Virulence.Herpes simplex virus 1 (HSV-1) for cancer treatment.Towards an effective genital herpes vaccine: past lessons and future prospects.Pathogen evasion strategies for the major histocompatibility complex class I assembly pathway.Mapping Murine Corneal Neovascularization and Weight Loss Virulence Determinants in the Herpes Simplex Virus 1 Genome and the Detection of an Epistatic Interaction between the UL and IRS/US RegionsEpstein-Barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-beta.Interaction of rotavirus with human myeloid dendritic cellsEnhanced reactivity of peripheral blood immune cells to HSV-1 in primary achalasia.
P2860
Q21089976-1D365413-CFF9-40E8-A05C-EB57EBDA72B7Q21090704-806E94BE-2F34-4F83-A4C9-02E08DB82723Q30350341-816BAB87-3A8C-4FF0-93EE-E6BCFC58D9F8Q33908810-C5408E49-946C-4751-BE9D-D8CF1FDA89CBQ34053075-26AE4F4A-0BD6-4BEB-9751-859ECB3F1358Q34545982-C9E57C09-1761-44F7-937E-DFD33874962BQ35220880-B860BA27-3101-4D9D-8B2C-62B77C01F0C0Q35758685-1A0DA92E-787D-4B5B-82CE-29514A9EE87FQ35952088-B09DFCDC-477A-43EE-BFE6-85E1CD48D5AFQ36444443-8959026B-A89A-4163-9BFD-B2FC0D1DCFC8Q36991575-3BD380DC-CF18-4C4A-B4DB-B68062B4985EQ37088488-29F73766-F2E6-46AA-AB08-CB6C7408422EQ37224825-5BA7667C-A641-42DF-968F-3AD59F2078B5Q39716669-9F97BF05-A4CB-4B92-8CFA-25645652984CQ39798531-D7D0C22E-2D01-421E-BC75-5EB42BBCF15AQ54429880-8FF6B29C-EFD1-4C61-A15F-AC8A97C0E894
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The host response to herpes simplex virus infection.
@ast
The host response to herpes simplex virus infection.
@en
type
label
The host response to herpes simplex virus infection.
@ast
The host response to herpes simplex virus infection.
@en
prefLabel
The host response to herpes simplex virus infection.
@ast
The host response to herpes simplex virus infection.
@en
P2093
P1476
The host response to herpes simplex virus infection.
@en
P2093
Benjamin M Chain
David R Katz
Gabriele Pollara
P304
P356
10.1097/00001432-200406000-00005
P577
2004-06-01T00:00:00Z